Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
DIA’s first-ever MedTech Conclave 2025 to focus on future of medical technology in India and beyond
DIA (Drug Information Association), a global community of life sciences professionals is all set to host the first-ever DIA…
Elevated Lp(a) raises CVD risk: Global experts call for action
Ahead of World Heart Day (29 September), Global Heart Hub and Novartis convened international healthcare experts for the…
Seven of ten pharma digital projects fail to deliver despite heavy spending: Vector study
A new study by Vector Consulting Group revealed that seven out of ten digital projects in India’s pharmaceutical industry fail to…
Lilly to build $6.5 billion API manufacturing facility in Texas
Eli Lilly and Company has announced its plan to build a new $6.5 billion manufacturing facility at Generation Park in Houston,…
Novartis releases new data on benefits of Kesimpta in relapsing multiple sclerosis
Novartis has released new data from two Kesimpta (ofatumumab) studies in relapsing multiple sclerosis (RMS) that will be presented…
Vidal Health and Serum Institute of India collaborate on HPV Vaccine access
Vidal Health, India’s second largest TPA service provider and Serum Institute of India, the world’s largest vaccine manufacturer,…
GDHS 2025: DCGI emphasises on balancing innovation with public safety
At Global Digital Health Summit (GDHS) 2025, Dr. Rajeev Raghuvanshi, Drugs Controller General of India (DCGI) emphasised on the…
Dr. Jitendra Sharma, MD & CEO of AMTZ joins IBEF’s Board of Trustees
The Ministry of Commerce & Industry has nominated Dr. Jitendra Sharma, Managing Director & CEO of Andhra Pradesh MedTech…
Dr. Reddy’s receives positive CHMP opinion from EMA for AVT03
Dr. Reddy’s Laboratories announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use…
Alkem launches Pertuza in India to treat HER2-positive breast cancer
Alkem Laboratories has announced the launch of Pertuza injection 420mg/14mL, a pertuzumab biosimilar, in India for the treatment…